Ge Healthcare Technologies Inc. revenue by segment GEHC

Ge Healthcare Technologies Inc. splits its revenue into 2 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $13.7 billion, 66% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Sep 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
Revenue
21,637
20,625
19,672
19,552
Product
14,270
+6.7%
share 66.0%
13,661
+4.5%
share 66.2%
13,075
-0.4%
share 66.5%
13,127
share 67.1%
Services
7,367
+7.2%
share 34.0%
6,964
+5.6%
share 33.8%
6,597
+2.7%
share 33.5%
6,425
share 32.9%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844)
Listed as
GEHC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Chicago, IL
SEC filer status
Large accelerated filer
SEC CIK
1932393
Former names
GE Healthcare Holding LLC (until Dec 14, 2022)

Other X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.